ClinicalTrials.gov
ClinicalTrials.gov Menu

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC) (TheraSphere)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00683631
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : October 21, 2013
Sponsor:
Collaborator:
MDS Pharma Services
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012